Background
==========

Literature on the ethics of returning research-generated genetic results to research participants has not reported on the practical experience of this activity. The Colon Cancer Family Registry (Colon CFR) has recruited participants from the US, Canada, Australia and New Zealand. Colon CFR-wide molecular testing has identified deleterious germline mutations in a DNA mismatch repair (MMR) gene for members of 424 families (153 *MLH1*, 206 *MSH2*, 39 *MSH6*, 26 *PMS2*). Carriers of mutations in these genes are at high risk of colorectal, endometrial and other cancers.

Aim
===

To document our diverse experiences in delivering clinically important genetic results and the uptake of genetic results by participants.

Methods
=======

When a deleterious MMR gene mutation is identified in a family member, predictive testing is conducted on all enrolled relatives of the carrier, and a letter offering to disclose this information is sent to all family members. If participants choose to receive their results, genetic counseling is provided to participants free of charge. Protocols for the four sites currently offering to return genetic results are shown in Table [1](#T1){ref-type="table"}.

###### 

Protocols for returning genetic results

  Steps in the protocol                                                         Ontario                           Mayo               Australasia                    Hawaii
  ----------------------------------------------------------------------------- --------------------------------- ------------------ ------------------------------ ------------------------
  **When do sites inform participants that genetic results may be available**   At enrolment                      At enrolment       At enrolment                   When results available
  **Who provides counseling (Genetic Counselor = GC)**                          GC shared by study and hospital   MD or GC           government-funded GC service   GC employed by study
  **Number of sessions**                                                        2                                 2                  2                              2
  **Mode of delivery of genetic results**                                       In person                         Telephone & mail   In person                      In person

Results
=======

Uptake of genetic test results by participants of families with MMR gene mutation results available ranged from 53-78%, (p=0.0001) (see Table [2](#T2){ref-type="table"}).

###### 

Uptake of genetic results

  -----------------------------------------------------------------------------------------
                                   Australasia\   Mayo\         Ontario\      Hawaii\
                                   (1999-2009)    (2008-2010)   (1998-2010)   (1998-2010)
  -------------------------------- -------------- ------------- ------------- -------------
  MMR mutation results available   805            185           260\*         17\*

  Had genetic counselling          504            145           197           12

  Received results                 493            144           179           9

  Decision pending                 15             12            23            3

  Uptake                           61%            78%           69%           53%
  -----------------------------------------------------------------------------------------

\* Probands only

Discussion
==========

The variation in uptake of genetic information could be related to the variation in the potential for insurance discrimination and/or the differences in the cost to consumers of genetic testing in the research and clinic setting.

Conclusions
===========

The return of genetic results and collection of uptake data has provided valuable information about the translation of these research findings and has led to translational research proposals. Delivering research-generated genetic results in the research setting, especially when sampling is population-based, provides both challenges and opportunities.
